More health systems across the U.S. are offering monoclonal antibody treatment as a way of fighting COVID-19 infection, but how exactly do the treatments work, and how effective are they in reducing ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

RSV is surging around the country after two seasons of low respiratory illnesses because of restrictions and public health measures to combat the coronavirus pandemic. There currently are no approved ...

Important adverse events included infusion-related and hypersensitivity reactions in 25 of 306 immunocompromised participants (8.2%) who received pemivibart and anaphylaxis in 4 of 623 participants (0 ...

Each year, respiratory syncytial virus (RSV) sends up to 80,000 kids under the age of five to the hospital; for hundreds of these children, complications caused by the virus are fatal. Various RSV ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Sept. 19, 2025 /PRNewswire/ -- The global veterinary monoclonal antibodies market, valued at ...

Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per ...

RSV, which stands for r espiratory syncytial virus, is surgi ng in number of cases and hospitalizations in young patients across the country. RSV can cause severe clinical problems in infants, ...